<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04720924</url>
  </required_header>
  <id_info>
    <org_study_id>2020SDU-QILU-1022</org_study_id>
    <nct_id>NCT04720924</nct_id>
  </id_info>
  <brief_title>AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract</brief_title>
  <official_title>Computer-aided Real-time Automatic Quality-control System for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract: a Multicenter Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Binzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Hospital of Shengli Oilfield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PKUcare luzhong hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linyi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zibo municipal hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of our study was to assess the performance of esophagogastroduodenoscopy&#xD;
      automatic quality-control system in real-time quality control of EGD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators developed a real-time quality control system of esophagogastroduodenoscopy(EGD)&#xD;
      named EGD automatic quality-control system (AQCS). Investigators carried a prospective&#xD;
      multicenter randomized controlled trial to assess the performance of this system in quality&#xD;
      control of real-time EGD, including detecting the early upper gastrointestinal cancer and&#xD;
      precancerous lesions, assessing inspection completeness, mucosal visibility, time of EGD&#xD;
      procedure and other indicators.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection rate of early cancer and precancerous lesions on upper gastrointestinal tract confirmed by pathological examination</measure>
    <time_frame>6 months</time_frame>
    <description>The primary outcome is the detection rate of early cancer and precancerous lesions on upper gastrointestinal tract confirmed by pathological examination per group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection rate of early cancer and precancerous lesions on upper gastrointestinal tract in tertiary hospitals and secondary hospitals.</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of detection rate of early cancer and precancerous lesions on upper gastrointestinal tract from tertiary hospitals and secondary hospitals with assistance of AQCS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean inspection completeness of two groups.</measure>
    <time_frame>6 months</time_frame>
    <description>Inspection completeness includes taking standard images of each parts of esophageal and gastric cavity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean inspection time of EGD procedure of two groups.</measure>
    <time_frame>During procedure</time_frame>
    <description>Inspection time of EGD procedure is the time endoscopy inserting to withdrawing the mouth and does not include the time of biopsy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection rate of early cancer and precancerous lesions on upper gastrointestinal tract from senior, intermediate and primary endoscopist with assistance of AQCS.</measure>
    <time_frame>6 months</time_frame>
    <description>Effect of detection rate of early cancer and precancerous lesions on upper gastrointestinal tract from senior, intermediate and primary endoscopist with assistance of AQCS.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1840</enrollment>
  <condition>Esophagogastroduodenoscopy</condition>
  <arm_group>
    <arm_group_label>AQCS-aided group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in AQCS-aided group will go through white light EGD examination with assistance of AQCS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in control group will go through white light EGD examination without AQCS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Computer-aided Real-time Automatic Quality-control System</intervention_name>
    <description>EGD automatic quality-control system(AQCS),developed based on deep convolutional neural network (DCNN) models,could facilitate real-time detection of upper gastrointestinal lesions, assess inspection completeness and mucosal visibility, and calculate time of EGD procedure.</description>
    <arm_group_label>AQCS-aided group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 40-80 years old&#xD;
&#xD;
          -  Patients scheduled for white light EGD examination with anaesthesia&#xD;
&#xD;
          -  American Society of Anesthesiology risk class 1, 2 or 3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known advanced esophageal or gastric cancer&#xD;
&#xD;
          -  Patients with a history of esophageal or gastric surgery&#xD;
&#xD;
          -  Patients scheduled for therapeutic EGD&#xD;
&#xD;
          -  Patients with stenosis or obstruction of upper gastrointestinal tract&#xD;
&#xD;
          -  Patients with a history of serious anesthesia-related complications&#xD;
&#xD;
          -  Patients in pregnancy or lactation phase&#xD;
&#xD;
          -  Patients refused to sign the informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanqing Li, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhen Li, PhD</last_name>
    <phone>18560086106</phone>
    <email>lizhenh@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruchen Zhou, MD</last_name>
    <phone>15949702165</phone>
    <email>sdlwzrc@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Binzhou Medical University Hospital</name>
      <address>
        <city>Binzhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiong Niu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linyi People's Hospital</name>
      <address>
        <city>Dezhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaodong Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Hospital of Shengli Oilfield</name>
      <address>
        <city>Dongying</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenqin Cui</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanqing Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>PKUcare Luzhong Hospital</name>
      <address>
        <city>Zibo</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shidong Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zibo Municipal Hospital</name>
      <address>
        <city>Zibo</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weidong Zhao</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 17, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>Esophagogastroduodenoscopy</keyword>
  <keyword>Gastric Cancer</keyword>
  <keyword>esophageal cancer</keyword>
  <keyword>Artificial Intelligence</keyword>
  <keyword>Quality-control</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

